News
MKKGY
30.52
+0.10%
0.03
Weekly Report: what happened at MKKGY last week (0831-0904)?
Weekly Report · 6d ago
Weekly Report: what happened at MKKGY last week (0824-0828)?
Weekly Report · 08/31 09:19
Weekly Report: what happened at MKKGY last week (0817-0821)?
Weekly Report · 08/24 09:19
Werewolf Therapeutics Takes Aim At Untapped Pain Market With Ambros Deal
Benzinga · 08/21 13:33
*Merck KGaA Cut to Neutral From Buy by UBS
Dow Jones · 08/20 09:52
Merck KGaA Prescription Drugs Could Lose Market Share -- Market Talk
Dow Jones · 08/20 09:22
Ariel International Fund Q2 2026 Portfolio Update
Seeking Alpha · 08/20 09:10
Weekly Report: what happened at MKKGY last week (0810-0814)?
Weekly Report · 08/17 09:19
Weekly Report: what happened at MKKGY last week (0803-0807)?
Weekly Report · 08/10 09:18
Ariel International (DM/EM) Q2 2026 Portfolio Activity
Seeking Alpha · 08/07 10:11
Merck KGaA GAAP EPS of €2.16, revenue of €5.4B
Seeking Alpha · 08/06 17:10
Stocks to Watch: Western Digital, Sandisk, Warner Bros Discovery, Ralph Lauren
The Wall Street Journal · 08/06 09:12
Ariel International Composite Q2 2026 Leaders, Laggards, Buys And Exits
Seeking Alpha · 08/06 06:00
Weekly Report: what happened at MKKGY last week (0727-0731)?
Weekly Report · 08/03 09:18
Weekly Report: what happened at MKKGY last week (0720-0724)?
Weekly Report · 07/27 09:19
Weekly Report: what happened at MKKGY last week (0713-0717)?
Weekly Report · 07/20 09:18
Revvity: Overvalued On Sentiment
Seeking Alpha · 07/13 16:41
Weekly Report: what happened at MKKGY last week (0706-0710)?
Weekly Report · 07/13 09:18
Weekly Report: what happened at MKKGY last week (0629-0703)?
Weekly Report · 07/06 09:19
Weekly Report: what happened at MKKGY last week (0622-0626)?
Weekly Report · 06/29 09:18
More
Webull provides a variety of real-time MKKGY stock news. You can receive the latest news about Merck Kgaa through multiple platforms. This information may help you make smarter investment decisions.
About MKKGY
Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business segment is operating in the therapeutic areas of oncology, neurology & immunology and fertility as well as cardiovascular, metabolic and endocrinological disorders. The Life Sciences segment is operating with its three business units such as, Science & Lab Solutions, Process Solutions and Life Science Services. It is also a supplier of products, tools and services for research laboratories, pharmaceutical and biopharmaceutical production as well as industrial and testing laboratories. The Electronics business segment consists of the Semiconductor Solutions, Display Solutions and Surface Solutions business units. Its Semiconductor Solutions business unit consists of the thin films, formulations, specialty gases, and delivery systems & services business fields.